Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 0 microdose metabolic profiling study of [14C]-GMC-252 in healthy male volunteers
NL-OMON34475Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of GMC-252 in type 2 diabetes mellitus (T2DM), sponsored by PRA Health Sciences. Primary endpoints: Pharmacokinetics, Metabolic profiling and 1 more. Started Oct 2010; status: active, not recruiting.
02
Drugs
GMC-252
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON34475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34475.